Most biopharma players need access to gene sequencing services. Illumina is facing a handful of headwinds, but it's still the market leader. Bionano Genomics is unproven but expanding quickly. So ...

Next-generation sequencing (NGS) has been an invaluable tool to understand both health and disease in many different organisms. However, for the most part, genomes are static replications of the ...

Illumina Inc. released Connected Insights in a beta version for the U.S., following its commercial release in other selected countries. Connected Insights, an assay-agnostic, cloud-based software ...

Beckman Coulter Life Sciences, a global leader in laboratory automation and innovation, in partnership with Illumina, a leader in DNA sequencing and array-based technologies, offers a promising new ...

Illumina Inc. ILMN recently announced the launch of Connected Insights -- a new cloud-based software that enables tertiary analysis for clinical next-generation sequencing (NGS) data. Connected ...

Illumina completed the spin-off of GRAIL in June 2024, retaining a 14.5% stake. The company is refocusing on its core DNA sequencing business, targeting high single-digit revenue growth by 2027. Q2 ...

Technological innovation stands as a significant driver propelling the next-generation sequencing (NGS) market growth, with continuous advancements in sequencing platforms, such as whole genome ...

Johan Strömqvist, PhD, has always been interested in “seeing” molecules, particularly in three dimensions (3D). Strömqvist worked with optical single-molecule imaging for his PhD and then founded a ...

Illumina, Commercial Metals and Newmont stand out as brokers boost ratings amid inflation concerns and shifting economic signals.